Major League Baseball delivered a stunning double blow to the National League East on Tuesday, announcing significant performance-enhancing drug (PED) suspensions for two key outfielders just weeks before Opening Day 2026. Atlanta Braves veteran Jurickson Profar has been handed a devastating 162-game suspension following a second positive test, effectively ending his season before it began. Simultaneously, Philadelphia Phillies center fielder Johan Rojas faces an 80-game ban after flagging for a banned substance, throwing the Phillies’ outfield depth into chaos. The simultaneous announcements have sent shockwaves through the division, forcing two World Series contenders to scramble for replacements as the 2026 season looms.

Jurickson Profar’s Career-Altering 162-Game Ban

The penalties hit hardest in Atlanta, where the loss of Jurickson Profar leaves a gaping hole in the middle of a lineup expected to contend for a division title. For Profar, 33, this marks a second career violation of MLB’s Joint Drug Prevention and Treatment Program. Under league rules, a second positive test triggers an automatic 162-game suspension without pay.

According to league sources, Profar tested positive for exogenous testosterone, a synthetic anabolic agent. The suspension will cost him his entire $15 million salary for the 2026 season. This comes on the heels of a tumultuous 2025 campaign where Profar served an 80-game suspension for a different substance before returning to post solid numbers in the second half.

“We were incredibly disappointed to learn of Jurickson’s positive test,” the Braves organization said in a terse statement released Tuesday evening. “We fully support MLB’s drug prevention program and will move forward with the players committed to winning in 2026.”

Financial and Roster Implications for Atlanta

The suspension voids the second year of the three-year, $42 million contract Profar signed in January 2025. While the Braves will save significant payroll—potentially freeing up luxury tax space—the on-field cost is steep. Profar was projected to be the primary designated hitter and a versatile outfield option.

With Profar moving to the restricted list, Atlanta’s front office is expected to pivot quickly. Internal options like Dominic Smith, who signed a minor-league deal earlier this winter, and Eli White are now frontrunners to absorb the vacated at-bats. However, rumors are already swirling that General Manager Alex Anthopoulos may look outside the organization, perhaps targeting a right-handed bat to balance the lineup.

Johan Rojas Facing 80 Games: Phillies Scramble for Depth

While Profar’s season is over, the Philadelphia Phillies are dealing with their own crisis. Center fielder Johan Rojas, 25, has been flagged for an 80-game suspension after testing positive for an undisclosed performance-enhancing substance. Reports indicate that Rojas is appealing the decision, a process that allows him to continue playing in Spring Training, but the looming ban casts a dark cloud over his 2026 outlook.

Rojas, known for his elite glove but inconsistent bat, was in the midst of a fierce battle for the starting center field job. The suspension essentially removes him from that competition, clarifying the roster picture in a way the Phillies hadn’t hoped for.

“It’s a distraction we didn’t need,” a Phillies source admitted on condition of anonymity. “We have depth, but losing a defender of Johan’s caliber hurts our late-game strategy.”

Next Man Up in Philadelphia

The Phillies are better positioned to absorb the loss than their division rivals, but the depth chart is thinning. The suspension all but guarantees that the newly acquired Adolis García and incumbent Brandon Marsh will shoulder the heavy lifting in the outfield, with rookie sensation Justin Crawford likely seeing accelerated playing time.

This incident marks the third PED-related issue for the Phillies organization in the last ten months, following suspensions to José Alvarado and former Phillie Max Kepler in 2025. The trend is raising uncomfortable questions for the front office, though manager Rob Thomson insisted Tuesday that the team remains focused on the field.

WBC Fallout and League-Wide Impact

The timing of the suspensions also disrupts the upcoming 2026 World Baseball Classic (WBC). Both players were slated to represent their respective nations—Profar for the Netherlands and Rojas for the Dominican Republic. Both have been immediately removed from their national team rosters, forcing last-minute changes just days before the tournament begins.

As the dust settles, the NL East landscape has shifted noticeably. The Braves lose a middle-of-the-order bat, and the Phillies lose their premier defensive specialist. With the New York Mets and Miami Marlins watching closely, the margin for error in baseball’s toughest division just got razor-thin.